Nutriband (NASDAQ:NTRB) Stock Price Up 1.4% – What’s Next?

Shares of Nutriband Inc. (NASDAQ:NTRB) shot up 1.4% during mid-day trading on Monday . The stock traded as high as $5.20 and last traded at $5.12. 6,122 shares changed hands during trading, a decline of 92% from the average session volume of 74,903 shares. The stock had previously closed at $5.05.

Analyst Upgrades and Downgrades

Separately, Noble Financial began coverage on Nutriband in a research note on Wednesday, January 22nd. They issued an “outperform” rating and a $13.00 price target on the stock.

Nutriband Price Performance

The firm has a fifty day moving average price of $6.23 and a two-hundred day moving average price of $5.78. The company has a quick ratio of 4.83, a current ratio of 4.96 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $56.86 million, a P/E ratio of -7.21 and a beta of 1.19.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Nutriband stock. Haven Private LLC bought a new stake in shares of Nutriband Inc. (NASDAQ:NTRB) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 11,561 shares of the company’s stock, valued at approximately $54,000. Haven Private LLC owned about 0.10% of Nutriband at the end of the most recent quarter. Institutional investors own 19.70% of the company’s stock.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.